Orphazyme A/S’s (NASDAQ: ORPH) Stock Could Appreciate By 49.01% – Marketing Sentinel
Home  »  Company   »  Orphazyme A/S’s (NASDAQ: ORPH) Stock Could Appre...

Orphazyme A/S’s (NASDAQ: ORPH) Stock Could Appreciate By 49.01%

In the last trading session, 1.6 million Orphazyme A/S (NASDAQ:ORPH) shares changed hands as the company’s beta touched 0. With the company’s per share price at $4.04 changed hands at $0.09 or 2.28% during last session, the market valuation stood at $149.84M. ORPH’s last price was a discount, traded about -1825.0% off its 52-week high of $77.77. The share price had its 52-week low at $3.78, which suggests the last value was 6.44% up since then. When we look at Orphazyme A/S’s average trading volume, we note the 10-day average is 1.22 million shares, with the 3-month average coming to 3.74 million.

Analysts gave the Orphazyme A/S (ORPH) stock a consensus recommendation rating of an Underweight, calculated at a mean rating of 4.00. If we narrow down to specifics, the data shows that 2 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended ORPH as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight. Orphazyme A/S’s EPS for the current quarter is expected to be $0.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

Orphazyme A/S (NASDAQ:ORPH) trade information

Instantly ORPH was in green as seen at the end of in last trading. With action 0.50%, the performance over the past five days has been green. The jump to weekly highs of 4.32 on Monday, 10/25/21 added 2.28% to the stock’s daily price. The company’s shares are showing year-to-date downside of -62.35%, with the 5-day performance at 0.50% in the green. However, in the 30-day time frame, Orphazyme A/S (NASDAQ:ORPH) is -8.18% down. Looking at the short shares, we see there were 0.43 million shares sold at short interest cover period of 0.14 days.

The consensus price target for the stock as assigned by Wall Street analysts is $1.53, meaning bulls need a downside of -164.05% from its current market value. According to analyst projections, ORPH’s forecast low is $1.00 with $2.06 as the target high. To hit the forecast high, the stock’s price needs a 49.01% surge from its current level, while the stock would need to tank 75.25% for it to hit the projected low.

Orphazyme A/S (ORPH) estimates and forecasts

Data shows that the Orphazyme A/S share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -59.19% over the past 6 months, a -105.85% in annual growth rate that is considerably lower than the industry average of 7.00%.

The 2021 estimates are for Orphazyme A/S earnings to decrease by -32.30%.

ORPH Dividends

Orphazyme A/S is expected to release its next quarterly earnings report in November.

Orphazyme A/S (NASDAQ:ORPH)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.00% of Orphazyme A/S shares while 2.25% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.25%. There are 2.25% institutions holding the Orphazyme A/S stock share, with Jane Street Group, LLC the top institutional holder. As of Jun 29, 2021, the company held 0.59% of the shares, roughly 0.2 million ORPH shares worth $1.5 million.

Susquehanna International Group, LLP holds the second largest percentage of outstanding shares, with 0.44% or 0.15 million shares worth $1.13 million as of Jun 29, 2021.

>> 7 Top Picks for the Post-Pandemic Economy <<

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam